Legal Representation
Attorney
Michael R. Rizzo
USPTO Deadlines
Next Deadline
69 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 01, 2025
Extension Available
Until October 01, 2025
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 21, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 21, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 21, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 21, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 21, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 26, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 25, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 25, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 5, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 5, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 5, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 1, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 6, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 6, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 17, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 1, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 26, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 30, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medical diagnostic kits comprising medical diagnostic reagents to be used in exposomic testing; medical diagnostic kits comprising medical diagnostic reagents for diagnosing autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic reagents and assays for testing hair samples
Class 009
Laboratory diagnostic kits comprised of a test tube for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer
Class 042
Medical and scientific research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer diagnosis; medical research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer treatment and diagnosis; laboratory research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for scientific research purposes
Class 044
Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic purposes in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for medical purposes
Classification
International Classes
005
009
042
044